Menu
Scroll to top

Georgia Wilkins

Reporter

Georgia Wilkins — Reporter

Georgia has worked as a journalist in Australia and overseas, including six years as a reporter for The Age and The Sydney Morning Herald. During this time, she worked as a business and finance reporter, covering corporate misconduct, multinational tax avoidance and wrongdoing at the big end of town. She also worked at The Weekly Review and the Phnom Penh Post, where she covered the Khmer Rouge Tribunal.

Can Australian companies escape doing deals with dictators?

Can Australian companies escape doing deals with dictators?

Few places are considered off limits for Australian mining companies operating in Africa, including Eritrea, one of the most repressed and politically unstable places in the world.

Dirty money and blurred lines

Dirty money and blurred lines

It’s the new frontier for Australian mining but our fraught expansion into Africa now goes back decades, and early missteps in the continent are proving hard to shake off.

The new frontier

The new frontier

Mining in Africa's developing nations can be fraught, with both small cap companies and governments looking to make sizable profits. But who are the winners and losers in this mad dash for cash?

Winning the hearts, minds (and pockets) of doctors

Winning the hearts, minds (and pockets) of doctors

If Novo Nordisk is to fulfil the potential of its anti-obesity drug Saxenda, it needs more doctors to have a new understanding of how obesity really works. And to prescribe. Again and again.

The commercial bet on obesity designed to ‘create the market’

The commercial bet on obesity designed to ‘create the market’

The race to find a pharmacological way to combat obesity is on — and in addition to financial pressures, it has proven devilishly difficult to make an obesity drug that is effective, safe and works at scale, across a population.

Is obesity a 'disease'? And, if it is, who wins?

Is obesity a 'disease'? And, if it is, who wins?

Getting doctors and medical bodies to classify obesity as a 'disease' would be a huge win for pharmaceutical companies. Here's how they're trying to do just that.

Obesity, politics, money and a company called Novo Nordisk

Obesity, politics, money and a company called Novo Nordisk

Novo Nordisk wants to change the way Australians think about obesity. And if it is successful, it could make a killing.

The Marist Brothers and a secret list of 154 accused child sex offenders

The Marist Brothers and a secret list of 154 accused child sex offenders

One hundred and fifty-four brothers have been accused of sexually assaulting students at Marist schools, but their identity and whether they are still teaching remains a secret.

Not waiting for Canberra: how powerful investors are taking on climate action

Not waiting for Canberra: how powerful investors are taking on climate action

Shareholders are demanding real action on climate change, but how can they make businesses deliver?

Uber for the dole: questions over government's gig economy plan

Uber for the dole: questions over government's gig economy plan

The government's latest welfare experiment looks to the gig economy for answers, but there are concerns that it will push jobseekers into dangerous, underpaid and exploitative work.